Emmaus Life Sciences, Inc.
EMMA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Lee Willis C: Form 4
Insider disclosure · Filed · Report period 30 May 2025
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- EMMA · 29137T101 - COMMON STOCK, PAR VALUE $0.001 PER SHARE
Company details and SEC sources
CIK 0000822370 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- EMMA on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 21250 Hawthorne Boulevard, Suite 800, Torrance, CA, 90503
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
MYnd Analytics Inc. (to 12 Jul 2019) CNS RESPONSE INC. (to 10 Dec 2015) STRATIVATION INC. (to 01 Mar 2007) SalesTactix Inc. (to 23 Aug 2005) AGE RESEARCH INC (to 05 Aug 2004)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields